The booming pet anti-infective drugs market, valued at $5.451 billion in 2025, is projected for significant growth through 2033, driven by rising pet ownership, healthcare spending, and innovative drug development. Learn about market trends, key players (Zoetis, Merck, Elanco), and regional insights in this comprehensive analysis.

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.